Estrogen [EPC]

Estrogen [EPC] was reported 186924 times

Drugs of the Estrogen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL CONTRACEPTIVE DEVICE EXPELLED 140 1.0000
1 CONTRALATERAL BREAST CANCER 165 0.8010
2 PROGESTERONE RECEPTOR ASSAY POSITIVE 719 0.7698
3 OESTROGEN RECEPTOR ASSAY POSITIVE 833 0.7346
4 OESTRADIOL DECREASED 175 0.5435
5 VAGINAL MYCOSIS 126 0.5408
6 VENA CAVA FILTER INSERTION 137 0.4349
7 BLOOD OESTROGEN DECREASED 302 0.4296
8 BREAST CANCER FEMALE 11060 0.4136
9 VULVOVAGINAL DISCOMFORT 1313 0.2968
10 ABNORMAL WITHDRAWAL BLEEDING 258 0.2804
11 WITHDRAWAL BLEED 199 0.2730
12 MENOPAUSAL SYMPTOMS 636 0.2730
13 FIBROCYSTIC BREAST DISEASE 173 0.2344
14 PRODUCT ADHESION ISSUE 8141 0.2276
15 VULVOVAGINAL INJURY 129 0.2263
16 OVARIAN CANCER METASTATIC 182 0.2141
17 ATROPHIC VULVOVAGINITIS 156 0.2134
18 MEDICAL DEVICE SITE DISCOMFORT 169 0.2105
19 BLOOD OESTROGEN INCREASED 122 0.2071
20 VULVOVAGINAL DRYNESS 663 0.2048
21 BREAST CANCER METASTATIC 2165 0.2014
22 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 184 0.1827
23 VULVOVAGINAL BURNING SENSATION 1109 0.1815
24 HYPERCOAGULATION 338 0.1773
25 VULVOVAGINAL ERYTHEMA 148 0.1770
26 POSTMENOPAUSAL HAEMORRHAGE 441 0.1690
27 VULVOVAGINAL PAIN 807 0.1674
28 MAMMOGRAM ABNORMAL 103 0.1537
29 VAGINAL DISORDER 146 0.1521
30 BREAST OPERATION 122 0.1491
31 PULMONARY INFARCTION 347 0.1466
32 CYSTOCELE 126 0.1450
33 INTRACRANIAL VENOUS SINUS THROMBOSIS 154 0.1437
34 PRODUCT SHAPE ISSUE 130 0.1376
35 BREAST CANCER 12719 0.1363
36 VAGINAL ODOUR 171 0.1358
37 VULVOVAGINAL PRURITUS 669 0.1320
38 SCHIZOAFFECTIVE DISORDER 234 0.1311
39 APPLICATION SITE HYPERSENSITIVITY 158 0.1300
40 APPLICATION SITE RASH 1720 0.1250
41 VULVOVAGINAL MYCOTIC INFECTION 483 0.1227
42 VULVOVAGINAL SWELLING 222 0.1214
43 BLADDER PROLAPSE 146 0.1194
44 APPLICATION SITE SCAR 147 0.1174
45 MEDICAL DEVICE DISCOMFORT 357 0.1167
46 SMEAR CERVIX ABNORMAL 160 0.1126
47 SOFT TISSUE DISORDER 124 0.1118
48 BREAST TENDERNESS 831 0.1102
49 DEVICE ADHESION ISSUE 1691 0.1101
50 APPLICATION SITE URTICARIA 242 0.1077
51 VAGINAL INFECTION 504 0.1070
52 CERVICAL DYSPLASIA 231 0.1057
53 METRORRHAGIA 1742 0.1021
54 BREAST CYST 179 0.1010
55 HORMONE LEVEL ABNORMAL 481 0.0985
56 APPLICATION SITE IRRITATION 1208 0.0970
57 UNINTENDED PREGNANCY 973 0.0930
58 VAGINAL DISCHARGE 916 0.0904
59 APPLICATION SITE PRURITUS 2029 0.0893
60 INCORRECT DOSE ADMINISTERED BY PRODUCT 139 0.0868
61 BACTERIAL VAGINOSIS 135 0.0863
62 MASTECTOMY 150 0.0857
63 PREGNANCY ON CONTRACEPTIVE 121 0.0828
64 ENDOMETRIAL CANCER 181 0.0822
65 APPLICATION SITE INFLAMMATION 113 0.0816
66 OVARIAN CANCER 749 0.0811
67 INTERMENSTRUAL BLEEDING 442 0.0790
68 PREMENSTRUAL SYNDROME 108 0.0785
69 APPLICATION SITE ERYTHEMA 1968 0.0750
70 NIPPLE PAIN 149 0.0731
71 UTERINE POLYP 131 0.0729
72 HOT FLUSH 5394 0.0715
73 DYSPAREUNIA 321 0.0698
74 PRODUCT PACKAGING ISSUE 657 0.0691
75 BREAST DISORDER 141 0.0690
76 EMBOLISM VENOUS 209 0.0688
77 BREAST SWELLING 185 0.0687
78 MATERNAL EXPOSURE BEFORE PREGNANCY 464 0.0679
79 PAPILLOMA VIRAL INFECTION 112 0.0678
80 MITRAL VALVE PROLAPSE 112 0.0672
81 CEREBRAL VENOUS THROMBOSIS 121 0.0666
82 APPLICATION SITE DISCOMFORT 117 0.0651
83 ACUTE SINUSITIS 112 0.0649
84 BREAST PAIN 686 0.0643
85 UTERINE DISORDER 148 0.0635
86 BREAST ENLARGEMENT 208 0.0634
87 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 150 0.0631
88 THROMBOPHLEBITIS SUPERFICIAL 190 0.0626
89 SPONDYLOLISTHESIS 106 0.0610
90 INVASIVE DUCTAL BREAST CARCINOMA 166 0.0610
91 UTERINE HAEMORRHAGE 258 0.0605
92 BREAST MASS 402 0.0598
93 BREAST CANCER RECURRENT 188 0.0595
94 MENOPAUSE 153 0.0593
95 PREGNANCY WITH CONTRACEPTIVE DEVICE 512 0.0571
96 DEEP VEIN THROMBOSIS 3714 0.0571
97 APPLICATION SITE BURN 278 0.0564
98 ESSENTIAL HYPERTENSION 103 0.0562
99 PNEUMONIA VIRAL 179 0.0561
100 UTERINE LEIOMYOMA 409 0.0559
101 PULMONARY EMBOLISM 5202 0.0547
102 APPLICATION SITE VESICLES 354 0.0545
103 MENSTRUAL DISORDER 445 0.0537
104 APPLICATION SITE SWELLING 266 0.0533
105 VAGINAL HAEMORRHAGE 2307 0.0531
106 PRE-EXISTING CONDITION IMPROVED 331 0.0530
107 OVARIAN CYST 526 0.0526
108 HYSTERECTOMY 453 0.0522
109 INTRAMEDULLARY ROD INSERTION 107 0.0522
110 APPLICATION SITE REACTION 365 0.0518
111 ENDOMETRIOSIS 247 0.0517
112 BLOOD PRESSURE SYSTOLIC ABNORMAL 126 0.0509
113 RHINITIS ALLERGIC 226 0.0507
114 APPLICATION SITE DISCOLOURATION 204 0.0502
115 INCORRECT DRUG ADMINISTRATION DURATION 1363 0.0484
116 TRICUSPID VALVE INCOMPETENCE 371 0.0466
117 SPINAL OSTEOARTHRITIS 407 0.0463
118 LOW TURNOVER OSTEOPATHY 185 0.0463
119 TEMPOROMANDIBULAR JOINT SYNDROME 123 0.0460
120 INTERVERTEBRAL DISC DEGENERATION 417 0.0450
121 MIGRAINE WITH AURA 122 0.0449
122 CHRONIC SINUSITIS 168 0.0447
123 HYPERPARATHYROIDISM SECONDARY 112 0.0447
124 PRODUCT PHYSICAL ISSUE 886 0.0439
125 MENORRHAGIA 862 0.0439
126 APPLICATION SITE PAIN 963 0.0437
127 NIGHT SWEATS 1408 0.0437
128 HYPERLIPIDAEMIA 506 0.0423
129 HEPATIC CYST 143 0.0421
130 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2961 0.0416
131 HYPOMENORRHOEA 114 0.0415
132 NEPHROGENIC ANAEMIA 192 0.0414
133 VARICOSE VEIN 213 0.0412
134 DIASTOLIC DYSFUNCTION 124 0.0401
135 DIVERTICULUM 276 0.0388
136 LUMBAR SPINAL STENOSIS 111 0.0379
137 DYSMENORRHOEA 500 0.0377
138 APPLICATION SITE HAEMORRHAGE 103 0.0377
139 HYPERTONIC BLADDER 108 0.0374
140 PLANTAR FASCIITIS 123 0.0366
141 FIBROMYALGIA 887 0.0364
142 DERMATITIS CONTACT 415 0.0364
143 COLITIS MICROSCOPIC 172 0.0363
144 SCOLIOSIS 223 0.0360
145 THROMBOPHLEBITIS 126 0.0359
146 STRESS FRACTURE 193 0.0357
147 ATELECTASIS 343 0.0355
148 POLYMENORRHOEA 123 0.0354
149 MACULOPATHY 125 0.0352
150 VITAMIN D DEFICIENCY 343 0.0351
151 OSTEOPENIA 530 0.0349
152 ANXIETY DISORDER 115 0.0344
153 PRODUCT SIZE ISSUE 185 0.0344
154 APPENDICECTOMY 122 0.0342
155 FUNGAL INFECTION 1117 0.0335
156 MIGRAINE 3162 0.0331
157 THERAPEUTIC PRODUCT INEFFECTIVE 128 0.0331
158 BODY HEIGHT DECREASED 351 0.0328
159 MITRAL VALVE INCOMPETENCE 371 0.0327
160 IRON DEFICIENCY ANAEMIA 302 0.0327
161 CAROTID ARTERY STENOSIS 114 0.0326
162 GOITRE 129 0.0315
163 SPINAL COLUMN STENOSIS 147 0.0311
164 BURSITIS 372 0.0306
165 THYROID DISORDER 467 0.0303
166 HIATUS HERNIA 392 0.0302
167 PRODUCT QUALITY ISSUE 4072 0.0300
168 PHLEBITIS 153 0.0299
169 PRODUCT RESIDUE PRESENT 161 0.0298
170 POST-TRAUMATIC STRESS DISORDER 199 0.0297
171 LIGAMENT SPRAIN 292 0.0295
172 MUSCLE STRAIN 255 0.0294
173 EXOSTOSIS 268 0.0293
174 MENISCUS INJURY 180 0.0292
175 CARPAL TUNNEL SYNDROME 406 0.0290
176 SLEEP APNOEA SYNDROME 553 0.0289
177 DEVICE BREAKAGE 1175 0.0289
178 AORTIC VALVE INCOMPETENCE 123 0.0289
179 PRODUCT SUBSTITUTION ISSUE 1662 0.0288
180 OSTEOARTHRITIS 1210 0.0285
181 PANIC DISORDER 110 0.0284
182 MOOD SWINGS 902 0.0283
183 INTERVERTEBRAL DISC DISORDER 120 0.0281
184 SNORING 106 0.0280
185 SYNOVIAL CYST 129 0.0279
186 PRODUCT ADMINISTRATION INTERRUPTED 219 0.0279
187 SPINAL STENOSIS 115 0.0278
188 PELVIC PAIN 498 0.0274
189 SPINAL FUSION SURGERY 111 0.0273
190 PRODUCT PRESCRIBING ERROR 651 0.0273
191 SEASONAL ALLERGY 384 0.0271
192 DEVICE PHYSICAL PROPERTY ISSUE 207 0.0270
193 APPLICATION SITE EXFOLIATION 111 0.0269
194 SYMPTOM RECURRENCE 161 0.0269
195 PRODUCT COLOUR ISSUE 138 0.0269
196 CYSTITIS 855 0.0268
197 BLADDER DISORDER 266 0.0268
198 MENSTRUATION DELAYED 290 0.0267
199 ABORTION INDUCED 251 0.0266
200 PLEURISY 158 0.0266
201 CHOLECYSTECTOMY 303 0.0265
202 GLUCOSE TOLERANCE IMPAIRED 155 0.0262
203 VITAMIN B12 DEFICIENCY 106 0.0262
204 ROTATOR CUFF SYNDROME 335 0.0261
205 POOR QUALITY DRUG ADMINISTERED 167 0.0258
206 TENSION HEADACHE 110 0.0256
207 BLOOD CHOLESTEROL INCREASED 1192 0.0255
208 SYNOVITIS 456 0.0253
209 CARDIAC MURMUR 216 0.0249
210 DRUG PRESCRIBING ERROR 478 0.0249
211 IRRITABLE BOWEL SYNDROME 532 0.0248
212 COELIAC DISEASE 243 0.0247
213 LIGAMENT RUPTURE 109 0.0246
214 FOOT OPERATION 121 0.0244
215 DYSLIPIDAEMIA 124 0.0244
216 HAIR GROWTH ABNORMAL 168 0.0242
217 OSTEOPOROSIS 997 0.0242
218 LEFT VENTRICULAR HYPERTROPHY 103 0.0240
219 MAJOR DEPRESSION 175 0.0239
220 MICTURITION URGENCY 273 0.0239
221 FOOT FRACTURE 447 0.0236
222 METASTASES TO LYMPH NODES 159 0.0235
223 TENDERNESS 244 0.0234
224 HAEMORRHOIDS 455 0.0233
225 NO ADVERSE EVENT 4223 0.0233
226 INTERVERTEBRAL DISC PROTRUSION 507 0.0232
227 EMOTIONAL DISORDER 711 0.0230
228 TENDONITIS 357 0.0230
229 RENAL CYST 181 0.0228
230 FRUSTRATION TOLERANCE DECREASED 183 0.0226
231 BRONCHITIS 1676 0.0226
232 DEVICE EXPULSION 1459 0.0225
233 POOR QUALITY SLEEP 484 0.0225
234 GASTROOESOPHAGEAL REFLUX DISEASE 1806 0.0224
235 CRYING 815 0.0224
236 COAGULOPATHY 373 0.0224
237 SINUSITIS 2286 0.0223
238 AFFECTIVE DISORDER 175 0.0222
239 VITAMIN D DECREASED 190 0.0222
240 HYPERCHOLESTEROLAEMIA 214 0.0221
241 LYMPHOEDEMA 153 0.0221
242 MIDDLE INSOMNIA 412 0.0220
243 MENINGIOMA 344 0.0220
244 COLITIS ISCHAEMIC 148 0.0219
245 PERIPHERAL VASCULAR DISORDER 113 0.0219
246 HEAVY MENSTRUAL BLEEDING 196 0.0218
247 MULTIPLE INJURIES 137 0.0217
248 TRANSIENT ISCHAEMIC ATTACK 733 0.0217
249 POOR QUALITY PRODUCT ADMINISTERED 227 0.0215
250 INFUSION SITE SWELLING 135 0.0214
251 MOOD ALTERED 582 0.0213
252 VENTRICULAR EXTRASYSTOLES 221 0.0213
253 PHARMACEUTICAL PRODUCT COMPLAINT 552 0.0212
254 AMENORRHOEA 372 0.0212
255 EMPHYSEMA 214 0.0212
256 PRODUCT USE COMPLAINT 334 0.0212
257 DEVICE FAILURE 322 0.0211
258 THROMBOSIS 1701 0.0211
259 CONCUSSION 163 0.0210
260 DEPRESSION 4763 0.0209
261 SCIATICA 332 0.0208
262 GALLBLADDER DISORDER 370 0.0207
263 RHINITIS 167 0.0207
264 NERVE COMPRESSION 191 0.0207
265 ANKLE FRACTURE 318 0.0205
266 URINARY INCONTINENCE 605 0.0204
267 THERAPEUTIC RESPONSE UNEXPECTED 916 0.0204
268 PHARYNGOLARYNGEAL PAIN 108 0.0203
269 RESTLESS LEGS SYNDROME 368 0.0202
270 BLOOD PRESSURE DIASTOLIC DECREASED 149 0.0202
271 POLYP 132 0.0201
272 CARDIAC FLUTTER 130 0.0201
273 INCREASED TENDENCY TO BRUISE 185 0.0201
274 LOW DENSITY LIPOPROTEIN INCREASED 155 0.0200
275 PHARYNGITIS 248 0.0200
276 FOOT DEFORMITY 221 0.0199
277 MULTIPLE ALLERGIES 156 0.0199
278 MUSCULOSKELETAL DISCOMFORT 342 0.0199
279 BONE DISORDER 362 0.0198
280 EAR PAIN 385 0.0198
281 WRONG TECHNIQUE IN DRUG USAGE PROCESS 719 0.0198
282 HYPOTHYROIDISM 631 0.0197
283 SPINAL DISORDER 187 0.0197
284 DIVERTICULITIS 547 0.0197
285 MALABSORPTION 103 0.0197
286 ARTHRITIS 1547 0.0196
287 UPPER-AIRWAY COUGH SYNDROME 162 0.0196
288 SINUS TACHYCARDIA 278 0.0196
289 BACK DISORDER 317 0.0195
290 MUSCULOSKELETAL CHEST PAIN 301 0.0194
291 BRAIN FOG 304 0.0194
292 CYST 240 0.0193
293 UPPER RESPIRATORY TRACT INFECTION 892 0.0193
294 CARDIOMEGALY 237 0.0192
295 SINUS DISORDER 381 0.0192
296 HERPES SIMPLEX 125 0.0192
297 HAND FRACTURE 136 0.0192
298 VISUAL DISTURBANCE 110 0.0192
299 URINARY TRACT INFECTION 3269 0.0191
300 SCAR 328 0.0191
301 FEELING DRUNK 142 0.0191
302 JAW DISORDER 104 0.0190
303 INCORRECT PRODUCT ADMINISTRATION DURATION 411 0.0190
304 MENSTRUATION IRREGULAR 507 0.0189
305 GASTROENTERITIS 276 0.0189
306 ABDOMINAL PAIN LOWER 478 0.0189
307 ARTHROPOD BITE 139 0.0187
308 DEVICE USE ISSUE 328 0.0187
309 HEART RATE IRREGULAR 423 0.0187
310 URINE ODOUR ABNORMAL 110 0.0187
311 GLAUCOMA 360 0.0187
312 UTERINE CANCER 150 0.0187
313 PRODUCT AVAILABILITY ISSUE 425 0.0186
314 BLOOD PRESSURE SYSTOLIC INCREASED 363 0.0186
315 SKIN ATROPHY 107 0.0186
316 POOR QUALITY DEVICE USED 186 0.0185
317 IMPAIRED GASTRIC EMPTYING 252 0.0185
318 SKIN REACTION 259 0.0184
319 HAIR DISORDER 151 0.0183
320 TOOTH FRACTURE 202 0.0183
321 INCORRECT PRODUCT STORAGE 240 0.0182
322 ABDOMINAL DISTENSION 1905 0.0182
323 NECK PAIN 1019 0.0182
324 NERVOUSNESS 952 0.0182
325 SINUS HEADACHE 108 0.0182
326 DENTAL CARIES 201 0.0182
327 IRRITABILITY 1090 0.0181
328 LACERATION 170 0.0181
329 PANIC ATTACK 658 0.0180
330 PALPITATIONS 2113 0.0180
331 TEMPERATURE INTOLERANCE 186 0.0180
332 CARDIAC VALVE DISEASE 103 0.0180
333 CHOLELITHIASIS 590 0.0180
334 HEPATIC STEATOSIS 335 0.0180
335 GASTRITIS 473 0.0180
336 ANXIETY 5115 0.0180
337 FLANK PAIN 168 0.0179
338 INSOMNIA 4757 0.0178
339 MEDICAL DEVICE COMPLICATION 132 0.0178
340 INFUSION SITE ERYTHEMA 150 0.0178
341 FEELING JITTERY 338 0.0177
342 NERVE INJURY 197 0.0177
343 FACIAL PAIN 158 0.0177
344 JOINT INJURY 377 0.0176
345 ECCHYMOSIS 121 0.0176
346 SINUS CONGESTION 238 0.0176
347 JOINT DISLOCATION 186 0.0176
348 PULMONARY MASS 262 0.0176
349 BACK INJURY 191 0.0175
350 OBESITY 279 0.0175
351 MUSCLE SPASMS 3205 0.0174
352 SUPRAVENTRICULAR TACHYCARDIA 167 0.0174
353 ARTERIOSCLEROSIS CORONARY ARTERY 115 0.0173
354 THERMAL BURN 123 0.0173
355 ACTIVITIES OF DAILY LIVING IMPAIRED 343 0.0173
356 HAIR TEXTURE ABNORMAL 231 0.0173
357 BURNING SENSATION 1210 0.0172
358 HELICOBACTER INFECTION 177 0.0172
359 BLOOD TRIGLYCERIDES INCREASED 304 0.0172
360 DEVICE DEFECTIVE 298 0.0172
361 BIPOLAR DISORDER 186 0.0171
362 SKIN LACERATION 186 0.0171
363 TOOTH ABSCESS 174 0.0171
364 CORONARY ARTERY DISEASE 517 0.0171
365 FEELING ABNORMAL 4091 0.0171
366 FEMUR FRACTURE 527 0.0170
367 PRODUCT FORMULATION ISSUE 112 0.0170
368 HYPERHIDROSIS 2174 0.0169
369 INCONTINENCE 178 0.0168
370 AUTOIMMUNE DISORDER 164 0.0168
371 WEIGHT FLUCTUATION 176 0.0168
372 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 308 0.0168
373 VISUAL FIELD DEFECT 121 0.0167
374 ORAL HERPES 325 0.0166
375 NOCTURIA 202 0.0166
376 DRUG LEVEL INCREASED 274 0.0165
377 JOINT EFFUSION 114 0.0165
378 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3346 0.0165
379 TOOTH INFECTION 217 0.0164
380 LIMB INJURY 447 0.0164
381 WRIST FRACTURE 197 0.0164
382 CHOLECYSTITIS CHRONIC 110 0.0164
383 FORMICATION 114 0.0164
384 WEIGHT INCREASED 3668 0.0164
385 PANIC REACTION 118 0.0163
386 PRODUCT ODOUR ABNORMAL 171 0.0163
387 ROAD TRAFFIC ACCIDENT 683 0.0163
388 FEELING HOT 998 0.0163
389 DISCOMFORT 993 0.0163
390 ECONOMIC PROBLEM 246 0.0162
391 IMPAIRED DRIVING ABILITY 184 0.0162
392 ANGINA UNSTABLE 105 0.0161
393 HYPERAESTHESIA 132 0.0161
394 TINNITUS 738 0.0160
395 CANDIDA INFECTION 270 0.0160
396 ORAL PAIN 358 0.0160
397 DYSURIA 588 0.0160
398 DRY EYE 797 0.0160
399 KIDNEY INFECTION 312 0.0159
400 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 537 0.0159
401 THINKING ABNORMAL 295 0.0158
402 TOOTHACHE 286 0.0158
403 ARTERIOSCLEROSIS 148 0.0157
404 EYE PAIN 885 0.0157
405 FOOD ALLERGY 121 0.0157
406 SLEEP DISORDER 1105 0.0156
407 RENAL FAILURE CHRONIC 120 0.0156
408 IMPAIRED WORK ABILITY 333 0.0156
409 ALOPECIA 3058 0.0156
410 POLLAKIURIA 649 0.0155
411 CHRONIC KIDNEY DISEASE 1178 0.0155
412 HEADACHE 9717 0.0155
413 MUSCLE TIGHTNESS 251 0.0155
414 KNEE OPERATION 152 0.0154
415 BODY TEMPERATURE DECREASED 152 0.0154
416 CHEST PAIN 2855 0.0154
417 LIMB DISCOMFORT 476 0.0154
418 INITIAL INSOMNIA 157 0.0153
419 NEURALGIA 372 0.0153
420 DRY THROAT 155 0.0152
421 HERPES ZOSTER 876 0.0152
422 OBSESSIVE-COMPULSIVE DISORDER 122 0.0152
423 PRODUCT ADMINISTRATION ERROR 307 0.0152
424 PARAESTHESIA ORAL 219 0.0152
425 PELVIC FRACTURE 118 0.0151
426 GROIN PAIN 133 0.0151
427 PULMONARY THROMBOSIS 164 0.0150
428 DEPRESSED MOOD 795 0.0150
429 SPINAL COMPRESSION FRACTURE 124 0.0150
430 PHARYNGITIS STREPTOCOCCAL 162 0.0150
431 PSYCHOLOGICAL TRAUMA 129 0.0149
432 INFUSION SITE PAIN 192 0.0149
433 HYPERTENSION 3149 0.0149
434 LUNG INFILTRATION 131 0.0148
435 GINGIVAL PAIN 118 0.0148
436 LIVER FUNCTION TEST ABNORMAL 431 0.0148
437 BACK PAIN 3443 0.0148
438 EYE INFECTION 167 0.0148
439 END STAGE RENAL DISEASE 269 0.0147
440 ORAL DISCOMFORT 204 0.0147
441 CONTUSION 1411 0.0146
442 PAIN IN JAW 414 0.0146
443 CEREBROVASCULAR ACCIDENT 2469 0.0146
444 EAR DISCOMFORT 149 0.0145
445 MACULAR DEGENERATION 173 0.0145
446 PAROSMIA 109 0.0144
447 LYMPHADENOPATHY 510 0.0144
448 BLOOD POTASSIUM DECREASED 433 0.0144
449 BLOOD THYROID STIMULATING HORMONE INCREASED 132 0.0143
450 ORAL DISORDER 105 0.0143
451 TOOTH DISORDER 318 0.0143
452 RIB FRACTURE 294 0.0143
453 MUSCULOSKELETAL PAIN 748 0.0143
454 POST PROCEDURAL COMPLICATION 274 0.0143
455 VERTIGO 869 0.0142
456 VITREOUS FLOATERS 140 0.0142
457 PULMONARY HYPERTENSION 296 0.0142
458 PHOTOPHOBIA 267 0.0142
459 PAIN IN EXTREMITY 4178 0.0142
460 SPINAL OPERATION 173 0.0140
461 CATARACT 836 0.0140
462 NEPHROLITHIASIS 643 0.0140
463 ASTHMA 1584 0.0140
464 BASAL CELL CARCINOMA 218 0.0140
465 MADAROSIS 162 0.0139
466 FEELING COLD 388 0.0139
467 LOCAL SWELLING 243 0.0139
468 PRODUCT DISPENSING ERROR 303 0.0139
469 ELECTROCARDIOGRAM ABNORMAL 109 0.0139
470 ARTHROPATHY 770 0.0138
471 RASH PAPULAR 310 0.0138
472 BLOOD PRESSURE INCREASED 2107 0.0138
473 DRUG ADMINISTERED AT INAPPROPRIATE SITE 145 0.0137
474 PHOTOSENSITIVITY REACTION 227 0.0137
475 LEUKOCYTOSIS 248 0.0137
476 EAR INFECTION 364 0.0137
477 OBSTRUCTIVE AIRWAYS DISORDER 152 0.0137
478 PHARYNGEAL OEDEMA 210 0.0136
479 AMNESIA 888 0.0136
480 DYSPEPSIA 1341 0.0136
481 OEDEMA PERIPHERAL 1660 0.0136
482 AFFECT LABILITY 131 0.0136
483 SWOLLEN TONGUE 425 0.0136
484 BLOOD DISORDER 109 0.0136
485 HEAD INJURY 430 0.0136
486 COORDINATION ABNORMAL 189 0.0135
487 CHOLECYSTITIS 161 0.0135
488 EXPIRED PRODUCT ADMINISTERED 449 0.0135
489 PYELONEPHRITIS 117 0.0135
490 DISTURBANCE IN ATTENTION 727 0.0135
491 ORAL CANDIDIASIS 177 0.0134
492 PRURITUS GENERALISED 290 0.0134
493 PERIPHERAL COLDNESS 184 0.0134
494 KNEE ARTHROPLASTY 282 0.0134
495 PRESYNCOPE 325 0.0134
496 INTENTIONAL PRODUCT MISUSE 1164 0.0133
497 ABORTION SPONTANEOUS 532 0.0133
498 FLUID RETENTION 675 0.0133
499 PARAESTHESIA 2082 0.0132
500 BLOOD PRESSURE ABNORMAL 263 0.0132
501 ANGINA PECTORIS 379 0.0132
502 HEART RATE INCREASED 1305 0.0132
503 HYPOAESTHESIA 1970 0.0131
504 DRY MOUTH 1067 0.0131
505 POOR VENOUS ACCESS 136 0.0131
506 BLOOD ALBUMIN DECREASED 104 0.0131
507 ANGER 442 0.0131
508 MENTAL DISORDER 568 0.0130
509 OROPHARYNGEAL PAIN 1208 0.0130
510 C-REACTIVE PROTEIN INCREASED 474 0.0130
511 SENSORY DISTURBANCE 209 0.0130
512 LOSS OF LIBIDO 117 0.0130
513 IMPAIRED QUALITY OF LIFE 187 0.0130
514 HEAD DISCOMFORT 230 0.0130
515 CAESAREAN SECTION 151 0.0130
516 APHONIA 181 0.0130
517 ABNORMAL DREAMS 358 0.0130
518 MUSCLE DISORDER 105 0.0130
519 SYSTEMIC LUPUS ERYTHEMATOSUS 460 0.0129
520 SMALL INTESTINAL OBSTRUCTION 159 0.0129
521 GASTROINTESTINAL PAIN 142 0.0129
522 MEMORY IMPAIRMENT 1766 0.0128
523 DRUG EFFECT DECREASED 692 0.0128
524 IMPAIRED HEALING 421 0.0128
525 MENTAL IMPAIRMENT 310 0.0128
526 CONTRAINDICATED PRODUCT ADMINISTERED 387 0.0128
527 BLOOD CALCIUM INCREASED 112 0.0128
528 ABDOMINAL PAIN 2968 0.0127
529 JOINT SWELLING 1534 0.0127
530 VIRAL INFECTION 421 0.0126
531 HYPERSENSITIVITY 2340 0.0126
532 UPPER LIMB FRACTURE 251 0.0126
533 PRODUCT USE ISSUE 2362 0.0126
534 HAIR COLOUR CHANGES 156 0.0125
535 SQUAMOUS CELL CARCINOMA 118 0.0125
536 ARTHRALGIA 5207 0.0125
537 SUICIDAL IDEATION 1146 0.0125
538 COLD SWEAT 220 0.0125
539 LIP SWELLING 415 0.0124
540 BLOOD PRESSURE FLUCTUATION 299 0.0124
541 PRODUCT PRESCRIBING ISSUE 271 0.0124
542 OSTEOMYELITIS 225 0.0124
543 GASTROENTERITIS VIRAL 224 0.0124
544 DYSPHONIA 724 0.0124
545 CHEST DISCOMFORT 1267 0.0124
546 DISEASE RECURRENCE 588 0.0123
547 BONE PAIN 724 0.0123
548 SURGERY 724 0.0123
549 BALANCE DISORDER 1067 0.0123
550 SWELLING FACE 803 0.0123
551 EATING DISORDER 261 0.0122
552 INJURY 861 0.0122
553 SWELLING 1140 0.0122
554 TYPE 2 DIABETES MELLITUS 410 0.0122
555 MASS 170 0.0122
556 HEART RATE DECREASED 426 0.0121
557 DIPLOPIA 315 0.0121
558 GASTRIC DISORDER 416 0.0121
559 FLATULENCE 687 0.0121
560 CELLULITIS 610 0.0121
561 SKIN DISORDER 402 0.0120
562 NASAL CONGESTION 708 0.0120
563 VISION BLURRED 1654 0.0120
564 TENDON RUPTURE 148 0.0120
565 LOWER LIMB FRACTURE 230 0.0120
566 CORONARY ARTERY OCCLUSION 164 0.0119
567 INFLUENZA LIKE ILLNESS 983 0.0119
568 RESPIRATORY RATE INCREASED 106 0.0119
569 OCULAR DISCOMFORT 134 0.0119
570 EYE IRRITATION 687 0.0119
571 NAUSEA 9410 0.0119
572 DIZZINESS 5917 0.0119
573 JOINT RANGE OF MOTION DECREASED 159 0.0118
574 INSURANCE ISSUE 181 0.0118
575 RESPIRATORY TRACT CONGESTION 187 0.0118
576 DIABETES MELLITUS 897 0.0118
577 DRUG ADMINISTRATION ERROR 360 0.0117
578 EYE SWELLING 436 0.0117
579 BLOOD IRON DECREASED 139 0.0117
580 RENAL PAIN 124 0.0117
581 ILLNESS 1204 0.0117
582 HYPOACUSIS 503 0.0117
583 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 641 0.0117
584 HYPERTHYROIDISM 169 0.0117
585 DEVICE MALFUNCTION 818 0.0116
586 DYSPNOEA EXERTIONAL 438 0.0116
587 OESOPHAGITIS 127 0.0116
588 CHROMATURIA 262 0.0116
589 HAEMATOCRIT DECREASED 230 0.0116
590 DECREASED ACTIVITY 125 0.0116
591 ANAL INCONTINENCE 104 0.0116
592 ANOREXIA 149 0.0116
593 HYPOAESTHESIA ORAL 174 0.0115
594 RASH PRURITIC 625 0.0115
595 PAIN 7070 0.0115
596 SCRATCH 121 0.0115
597 APPENDICITIS 107 0.0114
598 URTICARIA 1914 0.0114
599 ABDOMINAL PAIN UPPER 2348 0.0114
600 FEAR 306 0.0114
601 FLUSHING 1155 0.0114
602 THIRST 202 0.0113
603 MYALGIA 1920 0.0113
604 NODULE 147 0.0113
605 DERMATITIS 236 0.0113
606 QUALITY OF LIFE DECREASED 151 0.0112
607 APHASIA 339 0.0112
608 SKIN IRRITATION 514 0.0112
609 INCREASED APPETITE 214 0.0112
610 HYPERSOMNIA 321 0.0112
611 NIGHTMARE 386 0.0111
612 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 581 0.0111
613 BLISTER 625 0.0111
614 RENAL TUBULAR NECROSIS 109 0.0111
615 THERAPEUTIC PRODUCT EFFECT DECREASED 497 0.0111
616 INTENTIONAL DOSE OMISSION 316 0.0111
617 MALNUTRITION 124 0.0111
618 EYE DISORDER 364 0.0111
619 HUNGER 154 0.0110
620 WEIGHT DECREASED 3078 0.0110
621 JOINT STIFFNESS 289 0.0110
622 GASTRIC ULCER 209 0.0110
623 SKIN DISCOLOURATION 505 0.0110
624 CONSTIPATION 2394 0.0110
625 PRURITUS 4204 0.0109
626 FATIGUE 8507 0.0109
627 SPEECH DISORDER 571 0.0109
628 NASOPHARYNGITIS 2006 0.0109
629 THROAT IRRITATION 488 0.0109
630 ISCHAEMIC STROKE 194 0.0109
631 GINGIVAL BLEEDING 148 0.0108
632 INCORRECT DOSE ADMINISTERED BY DEVICE 284 0.0108
633 RESPIRATORY TRACT INFECTION 282 0.0108
634 TREMOR 1791 0.0108
635 MALAISE 4724 0.0108
636 HYPOKALAEMIA 497 0.0108
637 TOOTH EXTRACTION 134 0.0108
638 SINUS BRADYCARDIA 104 0.0107
639 RASH ERYTHEMATOUS 512 0.0107
640 HIP ARTHROPLASTY 164 0.0107
641 RHEUMATOID ARTHRITIS 1212 0.0107
642 GAIT DISTURBANCE 2035 0.0106
643 ABDOMINAL DISCOMFORT 1779 0.0106
644 FALL 3521 0.0106
645 THROAT TIGHTNESS 285 0.0105
646 BLOOD URINE PRESENT 200 0.0105
647 RHINORRHOEA 680 0.0105
648 PARANOIA 181 0.0105
649 ULCER 167 0.0105
650 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 504 0.0105
651 MUSCULAR WEAKNESS 1191 0.0105
652 OEDEMA 567 0.0104
653 WITHDRAWAL SYNDROME 439 0.0104
654 HEMIPARESIS 177 0.0104
655 PERIPHERAL SWELLING 1609 0.0104
656 ERUCTATION 202 0.0104
657 COGNITIVE DISORDER 487 0.0104
658 DYSGEUSIA 774 0.0104
659 EYELID PTOSIS 105 0.0103
660 HYPOKINESIA 150 0.0103
661 MUSCLE TWITCHING 238 0.0103
662 INTENTIONAL PRODUCT USE ISSUE 902 0.0103
663 BODY TEMPERATURE INCREASED 210 0.0103
664 PROCEDURAL PAIN 285 0.0103
665 DEAFNESS 268 0.0102
666 THERAPY CESSATION 525 0.0102
667 STAPHYLOCOCCAL INFECTION 337 0.0102
668 MOVEMENT DISORDER 326 0.0101
669 CHILLS 1188 0.0101
670 FREQUENT BOWEL MOVEMENTS 273 0.0101
671 RETCHING 215 0.0101
672 BLOOD SODIUM DECREASED 190 0.0101
673 INFLUENZA 1124 0.0101
674 DRUG INTOLERANCE 973 0.0101
675 DRUG INEFFECTIVE 13250 0.0100
676 MUSCULOSKELETAL STIFFNESS 880 0.0100
677 HAEMORRHAGE 1046 0.0100
678 WHITE BLOOD CELL COUNT INCREASED 382 0.0099
679 APATHY 145 0.0099
680 INFLAMMATION 512 0.0099
681 RECTAL HAEMORRHAGE 426 0.0099
682 SPINAL PAIN 116 0.0099
683 COUGH 2772 0.0099
684 ABASIA 244 0.0099
685 DYSSTASIA 288 0.0099
686 RASH MACULAR 344 0.0098
687 RASH 4280 0.0098
688 MUSCLE ATROPHY 124 0.0098
689 SNEEZING 219 0.0098
690 OFF LABEL USE 8541 0.0097
691 PLATELET COUNT INCREASED 127 0.0097
692 SKIN INFECTION 109 0.0097
693 ABSCESS 155 0.0097
694 SYNCOPE 971 0.0097
695 BACTERIAL INFECTION 181 0.0097
696 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 284 0.0097
697 MUSCULOSKELETAL DISORDER 184 0.0097
698 SECRETION DISCHARGE 121 0.0097
699 LETHARGY 555 0.0096
700 SCAB 110 0.0096
701 IMMUNE SYSTEM DISORDER 127 0.0096
702 RENAL INJURY 286 0.0096
703 CEREBRAL INFARCTION 235 0.0096
704 RASH GENERALISED 248 0.0096
705 DRUG EFFECT INCOMPLETE 347 0.0095
706 LACRIMATION INCREASED 288 0.0095
707 NEUROPATHY PERIPHERAL 906 0.0095
708 ASTHENIA 3577 0.0095
709 BLINDNESS UNILATERAL 134 0.0095
710 CONVULSION 543 0.0095
711 MOUTH ULCERATION 200 0.0095
712 RED BLOOD CELL SEDIMENTATION RATE INCREASED 105 0.0095
713 TOXIC EPIDERMAL NECROLYSIS 144 0.0095
714 PULMONARY CONGESTION 125 0.0095
715 WHEEZING 562 0.0095
716 HEPATIC ENZYME INCREASED 646 0.0095
717 GASTROINTESTINAL DISORDER 847 0.0094
718 DRUG EFFECT LESS THAN EXPECTED 140 0.0094
719 PREGNANCY 189 0.0094
720 CONDITION AGGRAVATED 2869 0.0094
721 COLITIS 357 0.0094
722 DISORIENTATION 373 0.0094
723 MULTIPLE SCLEROSIS 450 0.0094
724 DEVICE ISSUE 844 0.0094
725 DISABILITY 186 0.0094
726 ELECTROCARDIOGRAM QT PROLONGED 338 0.0094
727 GLOSSODYNIA 210 0.0094
728 EYE HAEMORRHAGE 125 0.0094
729 HEPATIC CIRRHOSIS 176 0.0094
730 MULTIPLE FRACTURES 153 0.0093
731 DRUG DOSE OMISSION 1531 0.0093
732 PRODUCTIVE COUGH 440 0.0092
733 PSORIATIC ARTHROPATHY 374 0.0092
734 INFECTION 1333 0.0092
735 CARDIOMYOPATHY 136 0.0092
736 VISUAL IMPAIRMENT 1138 0.0092
737 ECZEMA 480 0.0092
738 RESTLESSNESS 335 0.0091
739 FAECES DISCOLOURED 198 0.0091
740 DEMENTIA 254 0.0091
741 MYOCARDIAL INFARCTION 1583 0.0091
742 DEHYDRATION 1209 0.0091
743 DYSPHAGIA 860 0.0091
744 SKIN CANCER 195 0.0090
745 VOMITING 4250 0.0090
746 PRODUCT DOSE OMISSION 588 0.0090
747 ADVERSE EVENT 828 0.0090
748 SPINAL FRACTURE 180 0.0090
749 RESPIRATORY DEPRESSION 110 0.0090
750 LOCALISED INFECTION 217 0.0090
751 COVID-19 1573 0.0090
752 DRUG DISPENSING ERROR 137 0.0090
753 CARDIAC FAILURE CONGESTIVE 720 0.0090
754 DYSPNOEA 5074 0.0090
755 CARDIAC DISORDER 837 0.0089
756 TUBULOINTERSTITIAL NEPHRITIS 167 0.0089
757 RESPIRATORY DISORDER 265 0.0088
758 MENTAL STATUS CHANGES 246 0.0088
759 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 413 0.0088
760 DRUG INTERACTION 1400 0.0088
761 SKIN LESION 242 0.0088
762 AGEUSIA 220 0.0088
763 GENITAL HAEMORRHAGE 113 0.0088
764 ANOSMIA 127 0.0088
765 INJECTION SITE URTICARIA 215 0.0088
766 PRODUCT USE IN UNAPPROVED INDICATION 2167 0.0087
767 HERNIA 169 0.0087
768 PRESCRIBED OVERDOSE 169 0.0087
769 DIARRHOEA 5628 0.0087
770 BONE DENSITY DECREASED 273 0.0087
771 GAIT INABILITY 291 0.0087
772 HIP FRACTURE 280 0.0087
773 BLOOD ALKALINE PHOSPHATASE INCREASED 216 0.0087
774 ACUTE MYOCARDIAL INFARCTION 256 0.0087
775 CHOKING 169 0.0087
776 DYSARTHRIA 326 0.0087
777 PRODUCT TASTE ABNORMAL 117 0.0086
778 MANIA 142 0.0086
779 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 613 0.0086
780 BEDRIDDEN 113 0.0086
781 SOMNOLENCE 1731 0.0086
782 UNEVALUABLE EVENT 648 0.0086
783 PANCREATITIS 451 0.0085
784 ANHEDONIA 223 0.0085
785 FEEDING DISORDER 172 0.0085
786 CONJUNCTIVITIS 157 0.0085
787 OSTEONECROSIS OF JAW 209 0.0084
788 EYE PRURITUS 283 0.0084
789 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 143 0.0084
790 HAEMATOMA 218 0.0084
791 PLEURAL EFFUSION 511 0.0084
792 ATRIAL FIBRILLATION 817 0.0084
793 TREATMENT NONCOMPLIANCE 459 0.0084
794 INJECTION SITE WARMTH 172 0.0084
795 ANAEMIA 1575 0.0082
796 IMMUNODEFICIENCY 123 0.0082
797 PRODUCT DOSE OMISSION ISSUE 2426 0.0082
798 SKIN HAEMORRHAGE 122 0.0082
799 INJECTION SITE RASH 252 0.0082
800 CLOSTRIDIUM DIFFICILE INFECTION 179 0.0082
801 LOSS OF CONSCIOUSNESS 1050 0.0082
802 VENTRICULAR TACHYCARDIA 135 0.0082
803 PARALYSIS 117 0.0082
804 ARRHYTHMIA 387 0.0082
805 PRODUCT DOSE OMISSION IN ERROR 231 0.0081
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1468 0.0081
807 INJECTION SITE ERYTHEMA 1009 0.0081
808 BLINDNESS 331 0.0081
809 INTESTINAL OBSTRUCTION 305 0.0081
810 INJECTION SITE PRURITUS 542 0.0081
811 ACNE 611 0.0081
812 OCULAR HYPERAEMIA 381 0.0080
813 TACHYCARDIA 712 0.0080
814 PANCREATITIS ACUTE 180 0.0080
815 ERYTHEMA 1646 0.0080
816 CONFUSIONAL STATE 1288 0.0080
817 NERVOUS SYSTEM DISORDER 248 0.0079
818 PNEUMONIA 2558 0.0079
819 RENAL FAILURE 1048 0.0079
820 INFUSION RELATED REACTION 523 0.0079
821 VISUAL ACUITY REDUCED 262 0.0079
822 BLOOD TEST ABNORMAL 110 0.0078
823 PRODUCT COMPLAINT 198 0.0078
824 PULMONARY FIBROSIS 149 0.0078
825 DYSKINESIA 315 0.0077
826 HAEMOPTYSIS 215 0.0077
827 MALIGNANT MELANOMA 103 0.0077
828 INCORRECT DOSE ADMINISTERED 1753 0.0077
829 STOMATITIS 465 0.0077
830 RED BLOOD CELL COUNT DECREASED 219 0.0077
831 DEVICE DIFFICULT TO USE 505 0.0076
832 LOWER RESPIRATORY TRACT INFECTION 345 0.0076
833 DIABETES MELLITUS INADEQUATE CONTROL 134 0.0076
834 WOUND 211 0.0075
835 INJECTION SITE BRUISING 600 0.0075
836 INJECTION SITE HAEMATOMA 109 0.0075
837 SKIN ULCER 194 0.0075
838 ADVERSE DRUG REACTION 674 0.0075
839 MOBILITY DECREASED 538 0.0075
840 URINARY RETENTION 249 0.0075
841 COMPLICATION ASSOCIATED WITH DEVICE 108 0.0074
842 AGITATION 546 0.0074
843 RENAL DISORDER 345 0.0074
844 OXYGEN SATURATION DECREASED 415 0.0074
845 DRY SKIN 983 0.0074
846 PSYCHOMOTOR HYPERACTIVITY 122 0.0073
847 ACUTE RESPIRATORY FAILURE 140 0.0073
848 HAEMATOCHEZIA 401 0.0073
849 ORTHOSTATIC HYPOTENSION 126 0.0072
850 PAIN OF SKIN 194 0.0072
851 HAEMATURIA 246 0.0072
852 SKIN FISSURES 140 0.0072
853 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 122 0.0071
854 ASPARTATE AMINOTRANSFERASE INCREASED 377 0.0071
855 DERMATITIS ATOPIC 374 0.0071
856 UNDERDOSE 515 0.0070
857 DRUG-INDUCED LIVER INJURY 221 0.0070
858 LUNG INFECTION 109 0.0070
859 PERICARDIAL EFFUSION 161 0.0070
860 BLOOD PRESSURE DECREASED 462 0.0069
861 PRESCRIBED UNDERDOSE 138 0.0069
862 GOUT 124 0.0069
863 MEDICATION ERROR 382 0.0069
864 EPISTAXIS 513 0.0069
865 INTERNATIONAL NORMALISED RATIO INCREASED 194 0.0068
866 TASTE DISORDER 138 0.0068
867 RENAL FAILURE ACUTE 288 0.0068
868 DECREASED APPETITE 1575 0.0068
869 LEUKOPENIA 339 0.0068
870 COLITIS ULCERATIVE 302 0.0067
871 HEPATITIS 172 0.0067
872 ANAPHYLACTIC REACTION 371 0.0067
873 MULTIPLE SCLEROSIS RELAPSE 459 0.0067
874 LUNG DISORDER 328 0.0067
875 INJECTION SITE REACTION 460 0.0067
876 ILL-DEFINED DISORDER 405 0.0067
877 CARDIOVASCULAR DISORDER 169 0.0067
878 PSYCHOTIC DISORDER 195 0.0066
879 HYPERGLYCAEMIA 240 0.0066
880 THERAPEUTIC RESPONSE DECREASED 398 0.0066
881 PNEUMOTHORAX 104 0.0066
882 PYREXIA 2269 0.0066
883 FRACTURE 124 0.0065
884 ALANINE AMINOTRANSFERASE INCREASED 400 0.0065
885 PSORIASIS 850 0.0065
886 HYPONATRAEMIA 366 0.0065
887 SKIN EXFOLIATION 546 0.0065
888 THERAPEUTIC RESPONSE SHORTENED 214 0.0064
889 HYPOPHAGIA 164 0.0064
890 INJECTION SITE PAIN 1953 0.0064
891 TOOTH LOSS 132 0.0064
892 GLYCOSYLATED HAEMOGLOBIN INCREASED 160 0.0063
893 EMOTIONAL DISTRESS 765 0.0063
894 INTENTIONAL DRUG MISUSE 132 0.0063
895 INJECTION SITE SWELLING 483 0.0063
896 LYMPHOCYTE COUNT DECREASED 111 0.0063
897 BLOOD UREA INCREASED 105 0.0063
898 HALLUCINATION 472 0.0063
899 THERAPY NON-RESPONDER 281 0.0062
900 LABORATORY TEST ABNORMAL 184 0.0062
901 NEOPLASM MALIGNANT 415 0.0062
902 ABNORMAL BEHAVIOUR 245 0.0062
903 OSTEONECROSIS 202 0.0061
904 ACUTE KIDNEY INJURY 940 0.0061
905 LIVER DISORDER 271 0.0061
906 DRUG WITHDRAWAL SYNDROME 529 0.0060
907 HYPOTENSION 1206 0.0060
908 SEROTONIN SYNDROME 115 0.0060
909 HAEMOGLOBIN DECREASED 609 0.0059
910 DEVICE DELIVERY SYSTEM ISSUE 162 0.0059
911 DEPRESSED LEVEL OF CONSCIOUSNESS 233 0.0059
912 SEDATION 152 0.0058
913 SKIN BURNING SENSATION 412 0.0057
914 MATERNAL EXPOSURE DURING PREGNANCY 509 0.0057
915 HYPOXIA 201 0.0057
916 LIVER FUNCTION TEST INCREASED 121 0.0056
917 PRODUCT STORAGE ERROR 480 0.0055
918 PULMONARY OEDEMA 245 0.0055
919 HALLUCINATION, VISUAL 115 0.0054
920 AGGRESSION 270 0.0054
921 ANGIOEDEMA 237 0.0054
922 INJECTION SITE MASS 198 0.0053
923 INJECTION SITE HAEMORRHAGE 427 0.0053
924 HEPATOTOXICITY 118 0.0053
925 THERAPY INTERRUPTED 378 0.0053
926 EPILEPSY 159 0.0052
927 WHITE BLOOD CELL COUNT DECREASED 550 0.0051
928 PALLOR 137 0.0050
929 NEEDLE ISSUE 146 0.0050
930 TREATMENT FAILURE 414 0.0050
931 BRADYCARDIA 265 0.0050
932 HAEMATEMESIS 126 0.0050
933 BLOOD BILIRUBIN INCREASED 131 0.0048
934 UNRESPONSIVE TO STIMULI 125 0.0048
935 TARDIVE DYSKINESIA 133 0.0047
936 SEIZURE 544 0.0047
937 PNEUMONITIS 127 0.0047
938 EXPOSURE DURING PREGNANCY 289 0.0046
939 SUICIDE ATTEMPT 277 0.0046
940 DRUG EXPOSURE DURING PREGNANCY 155 0.0046
941 HYPOGLYCAEMIA 221 0.0046
942 EXPOSURE VIA SKIN CONTACT 117 0.0045
943 JAUNDICE 120 0.0045
944 CEREBRAL HAEMORRHAGE 158 0.0044
945 ANAPHYLACTIC SHOCK 112 0.0043
946 BLOOD GLUCOSE DECREASED 205 0.0043
947 ACCIDENTAL OVERDOSE 156 0.0043
948 GASTROINTESTINAL HAEMORRHAGE 356 0.0043
949 BLOOD GLUCOSE INCREASED 800 0.0042
950 ASCITES 124 0.0042
951 SEPSIS 468 0.0042
952 BLOOD CREATININE INCREASED 269 0.0041
953 CARDIAC ARREST 339 0.0041
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 118 0.0041
955 DELIRIUM 142 0.0041
956 RESPIRATORY FAILURE 298 0.0041
957 GENERAL PHYSICAL HEALTH DETERIORATION 471 0.0041
958 RENAL IMPAIRMENT 336 0.0040
959 RESPIRATORY DISTRESS 109 0.0039
960 DEVICE DISLOCATION 167 0.0038
961 LUNG NEOPLASM MALIGNANT 156 0.0038
962 HEPATIC FAILURE 114 0.0038
963 PLATELET COUNT DECREASED 387 0.0036
964 CARDIO-RESPIRATORY ARREST 148 0.0035
965 EXTRA DOSE ADMINISTERED 142 0.0035
966 METABOLIC ACIDOSIS 111 0.0035
967 RHABDOMYOLYSIS 141 0.0034
968 DEVICE LEAKAGE 140 0.0032
969 OVERDOSE 680 0.0031
970 HYPERKALAEMIA 108 0.0031
971 ACCIDENTAL EXPOSURE TO PRODUCT 314 0.0030
972 COMA 143 0.0030
973 THROMBOCYTOPENIA 334 0.0030
974 SEPTIC SHOCK 129 0.0030
975 NEUTROPHIL COUNT DECREASED 118 0.0029
976 PLASMA CELL MYELOMA 112 0.0029
977 INTERSTITIAL LUNG DISEASE 135 0.0028
978 CARDIAC FAILURE 216 0.0027
979 HOSPITALISATION 389 0.0025
980 PANCYTOPENIA 138 0.0025
981 DISEASE PROGRESSION 260 0.0022
982 DRUG DEPENDENCE 353 0.0022
983 COMPLETED SUICIDE 181 0.0022
984 INTENTIONAL OVERDOSE 139 0.0022
985 FEBRILE NEUTROPENIA 142 0.0021
986 TOXICITY TO VARIOUS AGENTS 355 0.0021
987 DRUG DOSE OMISSION BY DEVICE 154 0.0020
988 NEUTROPENIA 265 0.0019
989 FOETAL EXPOSURE DURING PREGNANCY 148 0.0018
990 MALIGNANT NEOPLASM PROGRESSION 141 0.0014
991 DEATH 1101 0.0013